DongKook Pharmaceutical Co., Ltd. (086450.KQ)
KRW 16350.0
(-1.57%)
KRW 16350.0
(-1.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 730.99 Billion | 661.64 Billion | 594.19 Billion | 559.1 Billion | 482.28 Billion | 400.8 Billion |
| Cost of Revenue | 325.95 Billion | 286.45 Billion | 248.19 Billion | 225.09 Billion | 194.56 Billion | 163.89 Billion |
| Gross Profit | 405.04 Billion | 375.19 Billion | 345.99 Billion | 334.01 Billion | 287.71 Billion | 236.9 Billion |
| Operating Expenses | 338.16 Billion | 302.93 Billion | 282.77 Billion | 251.4 Billion | 219 Billion | 181.79 Billion |
| Selling, General and Administrative Expenses | 312.71 Billion | 279.83 Billion | 258.08 Billion | 232.55 Billion | 199.11 Billion | 165.83 Billion |
| Research and Development Expenses | 25.45 Billion | 23.1 Billion | 24.69 Billion | 18.85 Billion | 19.89 Billion | 15.96 Billion |
| Other Expenses | - | 915.16 Million | 1.75 Billion | 280.55 Million | - | - |
| Cost and Expenses | 664.12 Billion | 589.39 Billion | 530.97 Billion | 476.5 Billion | 413.56 Billion | 345.69 Billion |
| Operating Income | 66.87 Billion | 72.25 Billion | 63.21 Billion | 82.6 Billion | 68.71 Billion | 55.11 Billion |
| Interest Expense | 5.86 Billion | 4.31 Billion | 2.88 Billion | 1.79 Billion | 2.52 Billion | 117.75 Million |
| Income Tax Expense | 11.96 Billion | 13.87 Billion | 16.83 Billion | 22.15 Billion | 16.57 Billion | 13.67 Billion |
| Earnings before Tax | 60.83 Billion | 67.51 Billion | 68.72 Billion | 79.57 Billion | 76.38 Billion | 63.1 Billion |
| Net Income | 47.17 Billion | 52.89 Billion | 50.34 Billion | 55.92 Billion | 56.31 Billion | 46.94 Billion |
| Earnings Per Share Basic | 1073.13 | 1203.46 | 1145.56 | 1272.52 | 1281.33 | 1068.27 |
| Earnings Per Share Diluted | 1054.64 | 1182.73 | 1125.82 | 1250.59 | 1259.25 | 1059.77 |
| Weighted Average Shares Outstanding | 43.96 Million | 43.95 Million | 43.94 Million | 43.94 Million | 43.94 Million | 43.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.73 Million | 44.72 Million | 44.71 Million | 44.71 Million | 44.71 Million | 44.3 Million |
| Gross Margin | 0.55 | 0.57 | 0.58 | 0.60 | 0.60 | 0.59 |
| EBIT Margin | 0.12 | 0.14 | 0.14 | 0.17 | 0.17 | 0.16 |
| Profit Margin | 0.06 | 0.08 | 0.08 | 0.10 | 0.12 | 0.12 |
| EBITDA | 88.68 Billion | 91 Billion | 80.56 Billion | 96.47 Billion | 82.32 Billion | 64.19 Billion |
| Earnings Before Tax Margin | 0.09 | 0.11 | 0.11 | 0.15 | 0.14 | 0.14 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 203.53 Billion | 196.82 Billion | 730.99 Billion | 187.87 Billion | 176.43 Billion | 185.87 Billion |
| Cost of Revenue | 92.56 Billion | 88.5 Billion | 325.95 Billion | 84.74 Billion | 77.67 Billion | 83.07 Billion |
| Gross Profit | 110.97 Billion | 108.31 Billion | 405.04 Billion | 103.13 Billion | 98.76 Billion | 102.8 Billion |
| Operating Expenses | 91.75 Billion | 87.62 Billion | 338.16 Billion | 82.67 Billion | 84.56 Billion | 89.89 Billion |
| Selling, General and Administrative Expenses | 84.08 Billion | 79.91 Billion | - | 77.04 Billion | 78.13 Billion | 82.87 Billion |
| Research and Development Expenses | 7.67 Billion | 7.71 Billion | - | 5.62 Billion | 6.43 Billion | 7.01 Billion |
| Other Expenses | -93.52 Billion | -340.87 Million | -113.56 Million | 244.68 Million | -565.91 Million | 46.42 Million |
| Cost and Expenses | 184.31 Billion | 176.12 Billion | 664.12 Billion | 167.41 Billion | 162.24 Billion | 172.96 Billion |
| Operating Income | 19.22 Billion | 20.69 Billion | 66.87 Billion | 20.46 Billion | 14.19 Billion | 12.9 Billion |
| Interest Expense | 1.47 Billion | 1.45 Billion | 5.86 Billion | 1.17 Billion | 1.53 Billion | 1.66 Billion |
| Income Tax Expense | 4.66 Billion | 5.14 Billion | 11.96 Billion | 3.54 Billion | 2.57 Billion | 1.51 Billion |
| Earnings before Tax | 17.02 Billion | 25 Billion | 61.73 Billion | 14.99 Billion | 14.81 Billion | 11.32 Billion |
| Net Income | 13.6 Billion | 19.68 Billion | 47.17 Billion | 9.06 Billion | 12.13 Billion | 9.94 Billion |
| Earnings Per Share Basic | 309.54 | 447.71 | - | 206.21 | 276.02 | 226.15 |
| Earnings Per Share Diluted | 304.21 | 440.00 | - | 202.66 | 271.26 | 222.26 |
| Weighted Average Shares Outstanding | 43.96 Million | 43.96 Million | 43.96 Million | 43.96 Million | 43.96 Million | 43.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.73 Million | 44.73 Million | 44.73 Million | 44.65 Million | 44.73 Million | 44.73 Million |
| Gross Margin | 0.55 | 0.55 | 0.55 | 0.55 | 0.56 | 0.55 |
| EBIT Margin | 0.13 | 0.14 | - | 0.14 | 0.11 | 0.10 |
| Profit Margin | 0.07 | 0.10 | 0.06 | 0.05 | 0.07 | 0.05 |
| EBITDA | 26.13 Billion | 27.31 Billion | - | 26.39 Billion | 19.13 Billion | 18.07 Billion |
| Earnings Before Tax Margin | 0.09 | 0.11 | 0.09 | 0.11 | 0.08 | 0.07 |
600872
0KBI
6464
9312
2883
HONT